Paul Hastings advised Morgan Stanley, Goldman Sachs and China Merchant Securities as the joint sponsors in Ascletis Pharma’s US$400 million global offering and Hong Kong IPO,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
